Abstract
The chapter reviews methods utilized for the isolation and characterization of a promising immunogen candidate, aiming at a human vaccine against paracoccidioidomycosis. Peptide P10 carries a T-CD4+ epitope and was identified as an internal sequence of the major diagnostic antigen known as gp43 glycoprotein. It successfully treated massive intratracheal infections by virulent Paracoccidioides brasiliensis in combination with chemotherapy.
An introduction about the systemic mycosis was found essential to understand the various options that were considered to design prophylactic and therapeutic vaccine protocols using peptide P10.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Theodoro RC, Teixeira MM, Felipe MSS et al (2012) Genus Paracoccidioides: species recognition and biogeographic aspects. PLoS One 7(5):e37694
Teixeira MM, Theodoro RC, Nino-Vega G et al (2014) Paracoccidioides species complex: ecology, phylogeny, sexual reproduction, and virulence. PLoS Pathog 10(10):e1004397
Bocca AL, Amaral AC, Teixeira MM et al (2013) Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues. Future Microbiol 8(9):1177–1191
Taborda CP, Urán ME, Nosanchuk JD et al (2015) Paracoccidioidomycosis: challenges in the development of a vaccine against an endemic mycosis in the Americas. Rev do Inst Med Trop São Paulo 57(Suppl 19):21–24
Prado M, Silva MB, Laurenti R et al (2009) Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz 104(3):513–521
Restrepo AM (1985) The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved. Sabouraudia 23(5):323–334
Oliveira HC, Assato PA, Marcos CM et al (2015) Paracoccidioides-host interaction: an overview on recent advances in the paracoccidioidomycosis. Front Microbiol 6:1319
Wanke B, Aidê MA (2009) Chapter 6 - paracoccidioidomycosis. J Bras Pneumol 35(12):1245–1249
Stover EP, Schar G, Clemons KV et al (1986) Estradiol-binding proteins from mycelial and yeast-form cultures of Paracoccidioides brasiliensis. Infect Immun 51(1):199–203
Loose DS, Stover EP, Restrepo A et al (1983) Estradiol binds to a receptor-like cytosol binding protein and initiates a biological response in Paracoccidioides brasiliensis. Proc Natl Acad Sci U S A 80(24):7659–7663
Franco M (1987) Host-parasite relationships in paracoccidioidomycosis. J Med Vet Mycol 25(1):5–18
Shikanai-Yasuda MA, Telles Filho FDQ, Mendes RP et al (2006) Consenso em paracoccidioidomicose. Rev Soc Bras Med Trop 39(3):297–310
Shikanai-Yasuda MA (2015) Paracoccidioidomycosis treatment. Rev Inst Med Trop São Paulo 57(Suppl 19):31–37
Tobón AM, Agudelo CA, Osorio ML et al (2003) Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis 37(7):898–904
MJS M-G, Monteiro da Silva JL, Fátima da Silva J et al (2008) Interactions of Paracoccidioides brasiliensis with host cells: recent advances. Mycopathologia 165(4–5):237–248
Benard G (2008) An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia 165(4–5):209–221
Camargo ZP, Franco MF (2000) Current knowledge on pathogenesis and immunodiagnosis of paracoccidioidomycosis. Rev Iberoam Micol 17(2):41–48
Marques SA (2012) Paracoccidioidomycosis. Clin Dermatol 30(6):610–615
Martinez R (2015) Epidemiology of paracoccidioidomycosis. Rev Inst Med Trop São Paulo 57(Suppl 19):11–20
Travassos LR, Taborda CP, Colombo AL (2008) Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti-Infect Ther 6(2):251–262
Fries BC, Taborda CP, Serfass E et al (2001) Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 108(11):1639–1648
Taborda CP, Rivera J, Zaragoza O et al (2003) More is not necessarily better: prozone-like effects in passive immunization with IgG. J Immunol 170(7):3621–3630
Taborda CP, Casadevall A (2001) Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J Immunol 166(3):2100–2107
Casadevall A, Pirofski L (2011) A new synthesis for antibody-mediated immunity. Nat Immunol 13(1):21–28
Albuquerque P, Casadevall A (2012) Quorum sensing in fungi – a review. Med Mycol 50(4):337–345
Buissa-Filho R, Puccia R, Marques AF et al (2008) The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus. Infect Immun 76(7):3321–3328
Gesztesi JL, Puccia R, Travassos LR et al (1996) Monoclonal antibodies against the 43,000 Da glycoprotein from Paracoccidioides brasiliensis modulate laminin-mediated fungal adhesion to epithelial cells and pathogenesis. Hybridoma 15(6):415–422
de Mattos Grosso D, de Almeida SR, Mariano M et al (2003) Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis. Infect Immun 71(11):6534–6542
Thomaz L, Nosanchuk JD, Rossi DCP et al (2014) Monoclonal antibodies to heat shock protein 60 induce a protective immune response against experimental Paracoccidioides lutzii. Microbes Infect 16(9):788–795
Travassos LR, Rodrigues EG, Iwai LK et al (2008) Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy. Mycopathologia 165(4–5):341–352
Benard G, Patzina RL, Schwab JB et al (2012) Fatal septic shock due to a disseminated chronic form of paracoccidioidomycosis in an aged woman. Med Mycol 50(4):407–411
Thind SK, Taborda CP, Nosanchuk JD (2015) Dendritic cell interactions with Histoplasma and Paracoccidioides. Virulence 6(5):424–432
Magalhães A, Ferreira KS, Almeida SR et al (2012) Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clin Vaccine Immunol 19(1):23–29
Braga CJ, Rittner GMG, Henao JEM et al (2009) Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin. Infect Immun 77(4):1700–1707
Arnon R (1986) Synthetic peptides as the basis for future vaccines. Trends Biochem Sci 11(12):521–524
Jiang S, Song R, Popov S et al (2006) Overlapping synthetic peptides as vaccines. Vaccine 24(37–39):6356–6365
Puccia R, Schenkman S, Gorin PAJ et al (1986) Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun 53(1):199–206
Taborda CP, Camargo ZP (1993) Diagnosis of paracoccidioidomycosis by passive haemagglutination assay of antibody using a purified and specific antigen-gp43. J Med Vet Mycol 31(2):155–160
Taborda CP, Camargo ZP (1994) Diagnosis of paracoccidioidomycosis by dot immunobinding assay for antibody detection using the purified and specific antigen gp43. J Clin Microbiol 32(2):554–556
Travassos LR, Puccia R, Cisalpino P et al (1995) Biochemistry and molecular biology of the main diagnostic antigen of Paracoccidioides brasiliensis. Arch Med Res 26(3):297–304
Puccia R, Takaoka DT, Travassos LR (1991) Purification of the 43 kDa glycoprotein from exocellular components excreted by Paracoccidioides brasiliensis in liquid culture (TOM medium). J Med Vet Mycol 29(1):57–60
Cisalpino PS, Puccia R, Yamauchi LM et al (1996) Cloning, characterization, and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis. J Biol Chem 271(8):4553–4560
Almeida IC, Neville DCA, Mehlert A et al (1996) Structure of the N-linked oligosaccharide of the main diagnostic antigen of the pathogenic fungus Paracoccidioides brasiliensis. Glycobiology 6(5):507–515
Taborda CP, Juliano MA, Puccia R et al (1998) Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun 66(2):786–793
Marques AF, da Silva MB, Juliano MAP et al (2006) Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother 50(8):2814–2819
Muñoz JE, Luft VD, Amorim J et al (2014) Immunization with P10 peptide increases specific immunity and protects immunosuppressed BALB/c mice infected with virulent yeasts of Paracoccidioides brasiliensis. Mycopathologia 178(3–4):177–188
Perez-Riverol Y, Sanchez A, Ramos Y et al (2011) In silico analysis of accurate proteomics, complemented by selective isolation of peptides. J Proteome 74(10):2071–2082
National Science Foundation (2006) Bradford protein assay protocol. 1–3
Perkins DN, Pappin DJ, Creasy DM et al (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20(18):3551–3567
Iwai LK, Yoshida M, Sidney J et al (2003) In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals. Mol Med 9(9–12):209–219
Leo KI, Yoshida M, Sadahiro A et al (2007) T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals. Clin Vaccine Immunol 14(4):474–476
Mayorga O, Muñoz JE, Lincopan N et al (2012) The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide. Front Microbiol 3:154
GMG R, Muñoz JE, Marques AF et al (2012) Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis. PLoS Negl Trop Dis 6(2):1–9
de Amorim J, Magalhães A, Muñoz JE et al (2013) DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells. Microbes Infect 15(3):181–191
Amaral AC, Marques AF, Muñoz JE et al (2010) Poly-lactic acid-glycolic acid nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis. Br J Pharmacol 159(5):1126–1132
Taborda CP, Nakaie CR, Cilli EM et al (2004) Synthesis and immunological activity of a branched peptide carrying the T-cell epitope of gp43, the major exocellular antigen of Paracoccidioides brasiliensis. Scand J Immunol 59(1):58–65
Lincopan N, Espíndola NM, Vaz AJ et al (2009) Novel immunoadjuvants based on cationic lipid: preparation, characterization and activity in vivo. Vaccine 27(42):5760–5771
Marques AF, da Silva MB, Juliano MAP et al (2008) Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis. Microbes Infect 10(12–13):1251–1258
Franco L, Najvar L, Gomez BL et al (1998) Experimental pulmonary fibrosis induced by Paracoccidioides brasiliensis conidia: measurement of local host responses. AmJTrop Med Hyg 58(4):424–430
Pinto AR, Puccia R, Diniz SN et al (2000) DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from Paracoccidioides brasiliensis. Vaccine 18:3050–3058
Kurokawa CS, Lopes CR, Sugizaki MF et al (2005) Virulence profile of ten Paracoccidioides brasiliensis isolates. Association with morphologic and genetic patterns. Rev Inst Med Trop São Paulo 47(5):257–262
Camargo ZP, Taborda CP, Rodrigues EG et al (1991) The use of cell-free antigens of Paracoccidioides brasiliensis in serological tests. J Med Vet Mycol 29(1):31–38
Acknowledgments
The authors thank Fundação de Amparo a Pesquisa do Estado de São Paulo (Fapesp) for research grants and the National Research Council (CNPq) for career fellowships.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Taborda, C.P., Travassos, L.R. (2017). Peptide Vaccine Against Paracoccidioidomycosis. In: Kalkum, M., Semis, M. (eds) Vaccines for Invasive Fungal Infections. Methods in Molecular Biology, vol 1625. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7104-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7104-6_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7103-9
Online ISBN: 978-1-4939-7104-6
eBook Packages: Springer Protocols